<table id="table2" width="80%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE II: MEAN (SD) PHARMACOKINETIC PARAMETERS OF NuvaRing<sup>Â®</sup> (n=16).</caption>
<col align="left" valign="top" width="20%"></col>
<col align="center" valign="top" width="20%"></col>
<col align="center" valign="top" width="20%"></col>
<col align="center" valign="top" width="20%"></col>
<col align="center" valign="top" width="20%"></col>
<thead>
<tr>
<th align="center">Hormone</th>
<th>C<sub>max</sub>
<br/>pg/mL</th>
<th>T<sub>max</sub>
<br/>hr</th>
<th>t<sub>1/2</sub>
<br/>hr</th>
<th>CL<br/>L/hr</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="5">C<sub>max</sub>- maximum serum drug concentration<br/>T<sub>max</sub>- time at which maximum serum drug concentration occurs<br/>t<sub>1/2</sub> - elimination half-life, calculated by 0.693/K<sub>elim</sub>
<br/>CL - apparent clearance</td>
</tr>
</tfoot>
<tbody>
<tr stylecode="Botrule">
<td>etonogestrel</td>
<td>1716 (445)</td>
<td>200.3 (69.6)</td>
<td>29.3 (6.1)</td>
<td>3.4 (0.8)</td>
</tr>
<tr>
<td>ethinyl estradiol</td>
<td>34.7 (17.5)</td>
<td>59.3 (67.5)</td>
<td>44.7 (28.8)</td>
<td>34.8 (11.6)</td>
</tr>
</tbody>
</table>